HK Stock MarketDetailed Quotes

PHARMARON (03759)

Watchlist
  • 20.140
  • +0.230+1.16%
Market Closed May 7 16:07 CST
36.86BMarket Cap19.22P/E (TTM)

PHARMARON (03759) Revenue Breakdown Overview

By Business/Source

Currency:CNY
2025/FY
Stock NameRevenueRatio
Laboratory services8.16B57.88%
CMC服务3.48B24.71%
Clinical research service1.96B13.88%
大分子和细胞与基因治疗服务474.69M3.37%
Other21.9M0.16%

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Laboratory services8.16B57.88%
CMC服务3.48B24.71%
Clinical research service1.96B13.88%
大分子和细胞与基因治疗服务474.69M3.37%
Other21.9M0.16%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
North America8.71B61.82%
Europe2.89B20.54%
The mainland of China2.14B15.16%
亚洲(不包括中国内地)298.44M2.12%
Other50.69M0.36%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More